SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-16-056920
Filing Date
2016-03-08
Accepted
2016-03-08 07:15:18
Documents
4
Period of Report
2016-03-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 EDGE THERAPEUTICS, INC. 8-K 3-8-2016 form8k.htm 8-K 18833
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 149456
3 image3.jpg GRAPHIC 1131
4 image00007.jpg GRAPHIC 4735
  Complete submission text file 0001140361-16-056920.txt   177749
Mailing Address 200 CONNELL DRIVE SUITE 1600 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1600 BERKELEY HEIGHTS NJ 07922 800-208-3343
Edge Therapeutics, Inc. (Filer) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37568 | Film No.: 161490286
SIC: 2834 Pharmaceutical Preparations